Biogen Inc - Company Profile
Powered by
All the data and insights you need on Biogen Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Biogen Inc Strategy Report
- Understand Biogen Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreView up-to-date information on Biogen Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
08 Sep 2022 | Autobahn Therapeutics Raises USD32.7 Million in Venture Financing | Venture Financing |
GT Healthcare Capital Partners LP
Bristol-Myers Squibb Co
Pfizer Ventures LLC
Section 32
BVF Partners LP
Alexandria Venture Investments
Invus Group LLC
ARCH Venture Partners LP
Cowen Healthcare Investments
Biogen Inc
Samsara BioCapital LLC
|
Autobahn Therapeutics Inc
|
06 Jun 2022 | Biogen Enters into Licensing Agreement with Alectos Therapeutics | Licensing Agreement |
Biogen Inc
|
Alectos Therapeutics
|
05 May 2022 | Biogen Enters into Licensing Agreement with MedRhythms | Licensing Agreement |
Biogen Inc
|
MedRhythms Inc
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer